Pancuronium pandemonium as doctors slam Hospira for execution injections
This article was originally published in Scrip
Executive Summary
An open letter published in the Lancet has criticised Hospira for its handling of the use of its muscle relaxant pancuronium bromide in executions in the US. However, Lundbeck, which faced a similar issue with its drug pentobarbital (Nembutal) for acute convulsive disorders, has emerged with its reputation intact. The letter praises the firm for its "truly exemplary" response to the situation after it tightened distribution of the drug.